Kinetic Concepts, Inc., is a global corporation that produces medical technology related to wounds and wound healing. KCI produced the first product developed specifically for negative pressure wound therapy. As of 2013 the company employs 5,000 people and markets its products in more than 25 countries. Its headquarters is in San Antonio, Texas. Wikipedia.
News Article | October 27, 2015
Acelity LP Inc., the San Antonio wound-care and regenerative-medicine company, posted a wider loss on slightly lower revenue in the third quarter ended Sept. 30. Formerly known as Kinetic Concepts Inc., Acelity lost nearly $10 million on $477.7 million in revenue in the latest quarter. That compares with a $1.8 million loss on $481.8 million in revenue in the same period last year. On an operating basis, Acelity reported $106.1 million in earnings in the latest period compared with $88.3 million a year ago. The company attributed the increase to “improved production yields,” primarily in its regenerative-medicine business. Both periods were impacted by significant interest expense.
News Article | January 26, 2015
(Bloomberg) -- Lifenet Health, a provider of organ donation and tissue banking services, was told by a federal court in Virginia that many of its requests to keep trade-secret information from being revealed in the transcript of a patent suit were too broadly written. Virginia Beach, Virginia-based Lifenet sued Kinetic Concepts Inc.’s Lifecell unit for patent infringement in federal court in Norfolk, Virginia, in September 2013. At issue was Lifenet’s patent 6,569,200, which covers plasticized soft-tissue grafts and methods of making and using them. In November 2014, a jury found that some of Lifecell products did infringe the patent and awarded Lifenet a lump sum royalty of $34.7 million. On Dec. 19, Lifenet asked the court to seal portions of the trial transcript. In a Jan. 9 order, U.S. District Judge Henry Coke Morgan Jr. denied the motion. He said that sealing as much of the transcript as Lifenet requested would deprive the public of “an opportunity to truly understand the issues in this case.” A “less drastic alternative” exists, the judge said. He said that instead of completely blanking out sections of the transcript relating to specific plasticizers, “a placeholder such as ‘plasticizer’ or ‘additive’ can be used.” This way, he said, public access could be protected, as well as Lifenet’s trade secrets. The case is Lifenet Health v. Lifecell Corp., 2:13-cv-00486, U.S. District Court, Eastern District of Virginia (Norfolk). For more patent news, click here. The Hershey Co., maker of chocolate bars and Reese’s Peanut Butter Cups, settled a trademark dispute with a New Jersey-based specialty food importer, according to a Jan. 22 court filing. The suit, filed on Aug. 25 in federal court in Harrisburg, Pennsylvania, alleged that LBB Imports LLC of Secaucus, New Jersey, was importing food products that infringe Hershey’s Reese’s, York, Maltesers, Cadbury, Rolo and Kit Kat trademarks. Hershey said the alleged infringement had continued since 2012, despite an agreement by LBB to stop importation of infringing products. The Hershey, Pennsylvania-based candy company asked the court to halt the sale of the infringing products and for money damages, attorney fees and litigation costs. Terms of the settlement weren’t disclosed in the court filing. The case was dismissed in response to Hershey’s request. It was dismissed without prejudice, which means that Hershey can file another suit against LBB Imports in the future. The case is Hershey Co. v. LBB Imports LLC, 1:14-cv-01655, U.S. District Court, Central District of Pennsylvania (Harrisburg). The Charles Darwin Foundation, which operates a research station on one of the Galapagos Islands, has shut down its gift shop following complaints from local merchants, according to the Economist. The islands’ municipal government refused to grant the gift shop a license unless it agreed to sell only items branded to the foundation, according to the newspaper. The shop’s purpose was to help fund the foundation’s operations on the island. An estimated $200,000 in revenue was expected in 2014 until operations were halted, the Economist reported. Swen Lorenz, the foundation’s chief executive officer, said the dispute needs to be heard by Ecuadorian officials rather than the islands’ local government, and the Economist reported that Ecuador’s ministries of the environment, agriculture and foreign relations have been made aware of the issue. For more trademark news, click here. Puma SE, the German maker of sporting goods and sporting apparel, was sued for trade secret misappropriation by Pairigi Group Ltd., a New York-based company that designs children’s clothing sold under a variety of brand names. The co-defendant is United Legware Co., a New York-based maker of underwear, socks and tights. The suit, filed in New York federal court, alleges Puma solicited confidential information from Pairigi and then shared it with United Legware as part of a scheme to bring the manufacturing of children’s apparel under the Puma brand from Pairigi to the hosiery company. Puma is accused of misrepresenting its intention to renew a license agreement with Pairigi with the aim of “diverting Parigi’s ‘‘economic and business opportunities’’ to itself. Pairigi also claims that Puma defamed it to companies for which the New York company had previously produced Puma products. Puma didn’t respond immediately to e-mail and phone requests for comment. The case is Pairigi Group Ltd. v. Puma North America Inc., 1:15-cv-00272, U.S. District Court, Southern District of New York (Manhattan). Beats Electronics LLC, a headphone maker co-founded by rapper Dr. Dre and acquired last year by Apple Inc. for $3 billion, was sued by the holder of the copyright to ‘‘Sin City,’’ a 1969 song by the Flying Burrito Brothers. According to the complaint filed Jan. 22 in federal court in Los Angeles, a music service offered by Santa Monica, California-based Beats is accused of making content available through a streaming service without permission from or payments to copyright holders. Zenbu Magazines LLC of Brooklyn, New York, filed the suit and is asking that the case be certified as a class action, saying that potential claimants are ‘‘so numerous’’ that it wouldn’t be practical for each to pursue a separate case. At issue are music recordings made before 1972. Earlier this month, Beats was sued in California state court by its one-time partner Monster LLC. In that suit, Beats, which sells Beats by Dr. Dre headphones, is accused of using a sham transaction to steal Monster’s technology as well as its distribution chain. In the new suit, Zenbu seeks compensation from Beats, including extra damages to punish the company. Beats didn’t immediately respond to an e-mail seeking comment on the suit. The case is Zenbu Magazines LLC v. Beats Electronics LLC, 2:15-cv-00464, U.S. District Court, Central District of California (Los Angeles). Belgian artist Luc Tuymans said he will appeal a court ruling of infringement relating to his use of a photo of politician Jean-Marie Dedecker as the source for one of his paintings, the U.K.’s Guardian reported. Tuymans, who based his painting on a photo by Katrijn van Giel used in a Belgian newspaper, claimed his work was a parody as permitted under European Union law, according to the Guardian. The court disagreed. It imposed a 500,000 Euro ($560,650) fine should the artist create additional paintings reproducing van Giel’s work or exhibit the painting on which the case is based, the Guardian reported. For more copyright news, click here. To contact the reporter on this story: Victoria Slind-Flor in San Francisco at firstname.lastname@example.org To contact the editors responsible for this story: Michael Hytha at email@example.com David Glovin, Joe Schneider
News Article | March 25, 2015
NuSil Technology LLC (http://www.nusil.com), the global leader in high purity medical and space-grade silicones, announces the appointment of Ernest Waaser as its new Chief Executive Officer. Mr. Waaser brings over 30 years of experience leading numerous public and privately-held healthcare companies. He takes over from NuSil’s co-founder and CEO, Dick Compton, who is retiring as CEO, but will continue to serve as Chairman of the NuSil Board of Directors. Prior to NuSil, Mr. Waaser was an Operating Partner at Linden Capital Partners and previous to that served as CEO of Systagenix Wound Management, a private equity-backed spinout of Johnson & Johnson’s advanced wound care unit, where he led the business through a period of growth resulting in a sale to Kinetic Concepts, Inc. Mr. Waaser spent his early career in various roles with DuPont’s chemical, industrial and imaging businesses. In the nearly two decades following his career at DuPont, Mr. Waaser held top leadership positions at a number of healthcare businesses, including President of Teleflex Medical, Chief Executive Officer of Hill-Rom, and Chief Operating Officer of Sterling Diagnostic Imaging, a leveraged buy-out of DuPont’s medical imaging assets. Mr. Waaser previously served on the board of AdvaMed and on the advisory board of Xavier University Department of Health Administration. He holds a Bachelor of Science in Nuclear Engineering from Mississippi State University and a Master of Engineering from the University of South Carolina. “We are thrilled to have an executive of Ernest’s caliber join the NuSil team,” said Matt Holt, a member of the Board of Directors and Managing Director at New Mountain Capital, NuSil’s majority shareholder. “With his proven track record of growing global Medtech businesses, we believe he is absolutely the right person to lead NuSil through its next phase of growth and expansion. Our ability to recruit this kind of talent speaks to the outstanding job that Dick Compton and the management team have done in building an exciting, growth oriented environment at NuSil. Dick is a true icon in the specialty silicone industry and we are pleased that he will continue as Chairman of the Board.” “I am delighted to be joining NuSil and I look forward to leading the growth of the outstanding company that Dick and the executive team have built,” said Mr. Waaser. “NuSil clearly differentiates itself with its high-touch, personalized approach to the customer experience. Combining that with its world class technical capabilities makes NuSil the partner of choice for the world’s most demanding silicone applications. I’m thrilled to lead an organization that truly delivers on its brand promise.” For more information, please contact NuSil at +1 805-684-8780, or visit http://www.nusil.com. About NuSil Technology LLC NuSil Technology, the global leader in medical and space-grade silicones, brings more than three decades of success in developing products for the most demanding applications, from deep inside the human body to the harsh conditions of outer space. It operates state-of-the-art laboratories and manufacturing facilities in North America and provides on-site, in-person application engineering support worldwide.
News Article | August 26, 2015
Wound care and regenerative medicine company Acelity yesterday said it expects to raise as much as $1 billion in its forthcoming initial public offering as it looks for a way to pay down its debt. Acelity, formerly Kinetic Concepts Inc., was acquired for $6.1 billion by Apax Partners and a pair of Canadian pension funds in a […]
News Article | July 24, 2015
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/8kcngp/global_wound_care) has announced the addition of the "Global Wound Care Markets (Twelve Country Analysis: Germany, France, Italy, United Kingdom, United States, Japan, Canada, China, India, Brazil, Australia, South Korea)" report to their offering. The report provides a competitive market summary. The wound care market is varied in terms of both product offerings and product maturity. Several of the products within the global wound care market are mature, such as anti-infectives and pressure relief devices, while others such as biological dressings and negative pressure wound therapy are in the infant stages of development. Advancements in biotechnology, biomaterials, and tissue engineering are expected to drive growth during the forecast period. Another area driving growth is that of negative pressure wound therapy. The wound care industry is an incredibly diverse and highly competitive arena that is ever-changing. Kalorama Information feels that the market will continue to expand over the long term due to an aging population, longer life expectancies, and an increasing number of sicker patients across all care settings. In the short term, there will be more ebb and flow in the industry due to changes in reimbursement, contract bidding, mergers and acquisitions, and changes in the delivery of health care. Patients have more complex coexisting illnesses such as diabetes, heart failure, obesity, pulmonary and vascular diseases, immobility issues and chronic wounds. These factors are all influenced by future demographic trends, economic uncertainty, the impact of health care reform, increasing numbers of uninsured patients, reimbursement pressures from third-party payers, continuing shortage of nurses and physicians and increasing technology and supply costs. Profiles of the major companies in the wound care market are provided: